問卷

TPIDB > Search Result

Search Result

篩選

List

1449Cases

2024-09-15 - 2029-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2023-06-01 - 2027-12-31

Phase I/II

Active
A Phase I/IIa Multi-center, Open-label Master Protocol Dose Escalation and Expansion Study of AZD8205 as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors (BLUESTAR)
  • Condition/Disease

    Advanced or metastatic solid malignancy

  • Test Drug

    AZD8205

Participate Sites
5Sites

Recruiting5Sites

2024-05-15 - 2032-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting3Sites

Recruiting3Sites

2024-06-01 - 2029-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2019-04-02 - 2025-10-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Terminated9Sites

2025-10-01 - 2029-12-31

Phase I/II

Active
xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    xxxxxx

Participate Sites
2Sites

Recruiting2Sites

2022-02-01 - 2029-12-31

Phase III

Active
A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre, International Study of NCT05211895
  • Condition/Disease

    Non-Small Cell Lung Cancer

  • Test Drug

    Durvalumab Domvanalimab

Participate Sites
9Sites

Recruiting9Sites

2014-08-09 - 2024-10-15

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Terminated6Sites

2024-09-01 - 2031-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites

2025-12-01 - 2029-06-30

Phase I/II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Not yet recruiting2Sites